Bhagawati Oxygen（509449）株式概要Bhagawati Oxygen Limited はインドで工業用ガスを製造・供給しています。 詳細509449 ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長0/6過去の実績2/6財務の健全性4/6配当金0/6報酬当社が推定した公正価値より2.1%で取引されている 今年は黒字化を達成 リスク分析意味のある時価総額がありません ( ₹81M )収益が 100 万ドル未満 ( ₹5M )Indian市場と比較した過去 3 か月間の株価の変動財務結果に影響を与える大きな一時的項目 すべてのリスクチェックを見る509449 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹34.9971.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-30m107m2016201920222025202620282031Revenue ₹4.9mEarnings ₹1.5mAdvancedSet Fair ValueView all narrativesBhagawati Oxygen Limited 競合他社National OxygenSymbol: BSE:507813Market cap: ₹363.1mRite Zone Chemcon IndiaSymbol: NSEI:RITEZONEMarket cap: ₹86.5mPadmanabh Alloy & PolymersSymbol: BSE:531779Market cap: ₹71.2mC.J. Gelatine ProductsSymbol: BSE:507515Market cap: ₹89.0m価格と性能株価の高値、安値、推移の概要Bhagawati Oxygen過去の株価現在の株価₹34.9952週高値₹56.0052週安値₹31.50ベータ0.211ヶ月の変化-1.85%3ヶ月変化-14.62%1年変化-39.23%3年間の変化-8.04%5年間の変化-10.05%IPOからの変化217.51%最新ニュースValuation Update With 7 Day Price Move • May 25Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹32.10, the stock trades at a trailing P/E ratio of 50.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 16% over the past three years.お知らせ • May 19Bhagawati Oxygen Limited to Report Q4, 2026 Results on May 29, 2026Bhagawati Oxygen Limited announced that they will report Q4, 2026 results on May 29, 2026Buy Or Sell Opportunity • Mar 11Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹42.00. The fair value is estimated to be ₹33.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.4% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Feb 07Third quarter 2026 earnings released: ₹0.33 loss per share (vs ₹0.89 loss in 3Q 2025)Third quarter 2026 results: ₹0.33 loss per share (improved from ₹0.89 loss in 3Q 2025). Revenue: ₹3.41m (up 31% from 3Q 2025). Net loss: ₹762.0k (loss narrowed 63% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 29Bhagawati Oxygen Limited to Report Q3, 2026 Results on Feb 06, 2026Bhagawati Oxygen Limited announced that they will report Q3, 2026 results on Feb 06, 2026New Risk • Dec 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹7.0m revenue, or US$79k). Market cap is less than US$10m (₹102.9m market cap, or US$1.15m). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results.最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • May 25Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹32.10, the stock trades at a trailing P/E ratio of 50.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 16% over the past three years.お知らせ • May 19Bhagawati Oxygen Limited to Report Q4, 2026 Results on May 29, 2026Bhagawati Oxygen Limited announced that they will report Q4, 2026 results on May 29, 2026Buy Or Sell Opportunity • Mar 11Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹42.00. The fair value is estimated to be ₹33.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.4% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Feb 07Third quarter 2026 earnings released: ₹0.33 loss per share (vs ₹0.89 loss in 3Q 2025)Third quarter 2026 results: ₹0.33 loss per share (improved from ₹0.89 loss in 3Q 2025). Revenue: ₹3.41m (up 31% from 3Q 2025). Net loss: ₹762.0k (loss narrowed 63% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 29Bhagawati Oxygen Limited to Report Q3, 2026 Results on Feb 06, 2026Bhagawati Oxygen Limited announced that they will report Q3, 2026 results on Feb 06, 2026New Risk • Dec 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹7.0m revenue, or US$79k). Market cap is less than US$10m (₹102.9m market cap, or US$1.15m). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results.Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹0.49 (vs ₹0.84 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.49 (up from ₹0.84 loss in 2Q 2025). Revenue: ₹5.94m (up 95% from 2Q 2025). Net income: ₹1.13m (up ₹3.06m from 2Q 2025). Profit margin: 19% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 07Bhagawati Oxygen Limited to Report Q2, 2026 Results on Nov 14, 2025Bhagawati Oxygen Limited announced that they will report Q2, 2026 results on Nov 14, 2025お知らせ • Sep 01Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2025Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2025, at 15:00 Indian Standard Time. Location: plot no. 5, sector - 25, ballabhgarh, haryana- 121004, haryana IndiaNew Risk • Aug 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹11m revenue, or US$122k). Market cap is less than US$10m (₹93.7m market cap, or US$1.06m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (6.8% average weekly change).お知らせ • Aug 02Bhagawati Oxygen Limited to Report Q1, 2026 Results on Aug 12, 2025Bhagawati Oxygen Limited announced that they will report Q1, 2026 results on Aug 12, 2025New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$1m (₹11m revenue, or US$125k). Market cap is less than US$10m (₹106.9m market cap, or US$1.25m).New Risk • May 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹11m revenue, or US$125k). Market cap is less than US$10m (₹140.2m market cap, or US$1.64m). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).お知らせ • May 22Bhagawati Oxygen Limited to Report Q4, 2025 Results on May 30, 2025Bhagawati Oxygen Limited announced that they will report Q4, 2025 results on May 30, 2025Reported Earnings • Feb 14Third quarter 2025 earnings released: ₹0.89 loss per share (vs ₹2.25 loss in 3Q 2024)Third quarter 2025 results: ₹0.89 loss per share (improved from ₹2.25 loss in 3Q 2024). Net loss: ₹2.06m (loss narrowed 61% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.お知らせ • Feb 04Bhagawati Oxygen Limited to Report Q3, 2025 Results on Feb 12, 2025Bhagawati Oxygen Limited announced that they will report Q3, 2025 results on Feb 12, 2025New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹8.4m revenue, or US$98k). Market cap is less than US$10m (₹147.9m market cap, or US$1.73m). Minor Risk Share price has been volatile over the past 3 months (7.6% average weekly change).お知らせ • Nov 06Bhagawati Oxygen Limited to Report Q2, 2025 Results on Nov 14, 2024Bhagawati Oxygen Limited announced that they will report Q2, 2025 results on Nov 14, 2024Board Change • Sep 07Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Sanjay Rai was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Sep 03Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2024Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2024, at 15:00 Indian Standard Time. Location: plot no. 5, sector - 25, ballabhgarh, haryana- 121004, haryana IndiaValuation Update With 7 Day Price Move • Aug 30Investor sentiment improves as stock rises 34%After last week's 34% share price gain to ₹70.97, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years.New Risk • Aug 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹6.5m revenue, or US$77k). Market cap is less than US$10m (₹148.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹52.52, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 53% over the past three years.Reported Earnings • Aug 11First quarter 2025 earnings released: ₹0.84 loss per share (vs ₹4.30 loss in 1Q 2024)First quarter 2025 results: ₹0.84 loss per share (improved from ₹4.30 loss in 1Q 2024). Net loss: ₹1.95m (loss narrowed 80% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 31Bhagawati Oxygen Limited to Report Q1, 2025 Results on Aug 08, 2024Bhagawati Oxygen Limited announced that they will report Q1, 2025 results on Aug 08, 2024New Risk • Jun 04New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 64% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (64% accrual ratio). Revenue is less than US$1m (₹71m revenue, or US$851k). Market cap is less than US$10m (₹99.4m market cap, or US$1.19m). Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change).Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹1.78 (vs ₹10.47 loss in FY 2023)Full year 2024 results: EPS: ₹1.78 (up from ₹10.47 loss in FY 2023). Revenue: ₹71.1m (up ₹63.7m from FY 2023). Net income: ₹4.11m (up ₹28.3m from FY 2023). Profit margin: 5.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • May 19Bhagawati Oxygen Limited to Report Q4, 2024 Results on May 30, 2024Bhagawati Oxygen Limited announced that they will report Q4, 2024 results on May 30, 2024Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹51.54, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 94% over the past three years.Reported Earnings • Feb 14Third quarter 2024 earnings released: ₹2.25 loss per share (vs ₹3.37 loss in 3Q 2023)Third quarter 2024 results: ₹2.25 loss per share (improved from ₹3.37 loss in 3Q 2023). Revenue: ₹700.0k (down 48% from 3Q 2023). Net loss: ₹5.21m (loss narrowed 33% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 44% per year whereas the company’s share price has increased by 46% per year.Valuation Update With 7 Day Price Move • Dec 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹44.10, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 139% over the past three years.Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹15.70 (vs ₹1.27 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹15.70 (up from ₹1.27 loss in 2Q 2023). Revenue: ₹66.6m (up ₹63.7m from 2Q 2023). Net income: ₹36.3m (up ₹39.2m from 2Q 2023). Profit margin: 55% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Sep 05Bhagawati Oxygen Limited, Annual General Meeting, Sep 27, 2023Bhagawati Oxygen Limited, Annual General Meeting, Sep 27, 2023, at 13:00 Indian Standard Time. Location: Plot No. 5, Sector- 25, Ballabhgarh Haryana India Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the Report of the Directors and Auditors thereon; to appoint a Director in place of Mr. Suresh Kumar Sharma who retires by rotation at this Annual General Meeting and being eligible offers himself for re-appointment; to consider reappointment of Mr. Suresh Kumar Sharmaas the whole-time director; to consider reappointment of Mr. Himanshu Sharmaas the managing director; and to consider appointment of Mr. Sanjay Kumar Raias an independent director.お知らせ • Aug 04Bhagawati Oxygen Limited to Report Q1, 2024 Results on Aug 11, 2023Bhagawati Oxygen Limited announced that they will report Q1, 2024 results After-Market on Aug 11, 2023Reported Earnings • Jun 01Full year 2023 earnings released: ₹10.47 loss per share (vs ₹12.19 loss in FY 2022)Full year 2023 results: ₹10.47 loss per share (improved from ₹12.19 loss in FY 2022). Net loss: ₹24.2m (loss narrowed 14% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.お知らせ • May 23Bhagawati Oxygen Limited to Report Fiscal Year 2023 Results on May 30, 2023Bhagawati Oxygen Limited announced that they will report fiscal year 2023 results on May 30, 2023Reported Earnings • Feb 16Third quarter 2023 earnings released: ₹3.37 loss per share (vs ₹3.54 loss in 3Q 2022)Third quarter 2023 results: ₹3.37 loss per share (improved from ₹3.54 loss in 3Q 2022). Net loss: ₹7.81m (loss narrowed 4.7% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 82% per year, which means it is well ahead of earnings.お知らせ • Feb 04Bhagawati Oxygen Limited to Report Q3, 2023 Results on Feb 14, 2023Bhagawati Oxygen Limited announced that they will report Q3, 2023 results on Feb 14, 2023Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 4 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Bipin Lal was the last independent director to join the board, commencing their role in 2003. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 05Bhagawati Oxygen Limited to Report Q2, 2023 Results on Nov 12, 2022Bhagawati Oxygen Limited announced that they will report Q2, 2023 results on Nov 12, 2022お知らせ • Aug 26Bhagawati Oxygen Limited, Annual General Meeting, Sep 20, 2022Bhagawati Oxygen Limited, Annual General Meeting, Sep 20, 2022, at 13:00 Indian Standard Time. Location: No. 5, Sector - 25, Ballabhgarh, Haryana- 121004 Ballabhgarh Haryana India Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Report of the Directors and Auditors thereon; to consider appoint Director in place of Mrs Jaya Sharma who retires by rotation at this Annual General Meeting and being eligible offers herself for re-appointment; and to consider other matters.Reported Earnings • Aug 14First quarter 2023 earnings released: ₹2.99 loss per share (vs ₹2.71 loss in 1Q 2022)First quarter 2023 results: ₹2.99 loss per share (down from ₹2.71 loss in 1Q 2022). Net loss: ₹6.91m (loss widened 10% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.お知らせ • May 21Bhagawati Oxygen Limited to Report Q4, 2022 Results on May 27, 2022Bhagawati Oxygen Limited announced that they will report Q4, 2022 results on May 27, 2022Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 4 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Bipin Lal was the last independent director to join the board, commencing their role in 2003. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: ₹3.54 loss per share (up from ₹3.90 loss in 3Q 2021). Net loss: ₹8.19m (loss narrowed 9.2% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 04Full year 2021 earnings released: ₹13.42 loss per share (vs ₹0.27 loss in FY 2020)Full year 2021 results: Net loss: ₹31.0m (loss widened ₹30.4m from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 17Third quarter 2021 earnings released: ₹3.90 loss per share (vs ₹3.74 profit in 3Q 2020)Third quarter 2021 results: Net loss: ₹9.02m (down 204% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 76% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings.お知らせ • Feb 04Bhagawati Oxygen Limited to Report Q3, 2021 Results on Feb 12, 2021Bhagawati Oxygen Limited announced that they will report Q3, 2021 results on Feb 12, 2021Is New 90 Day High Low • Jan 29New 90-day low: ₹12.45The company is down 21% from its price of ₹15.80 on 30 October 2020. The Indian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Dec 08New 90-day high: ₹19.05The company is up 2.0% from its price of ₹18.75 on 09 September 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.お知らせ • Dec 04Bhagawati Oxygen Limited, Annual General Meeting, Dec 30, 2020Bhagawati Oxygen Limited, Annual General Meeting, Dec 30, 2020, at 15:00 Indian Standard Time. Location: at the Registered Office of the Company at Plot No. 5, Sector - 25, Ballabgarh Haryana India Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2020, together with the Report of the Directors and Auditors thereon; and to re-appoint a Director in place of Ms Jaya Sharma (DIN 07135989) who retire by rotation at this Annual General Meeting and being eligible offers herself for re-appointment.Is New 90 Day High Low • Nov 10New 90-day low: ₹12.55The company is down 8.0% from its price of ₹13.70 on 12 August 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.お知らせ • Nov 04Bhagawati Oxygen Limited to Report Q2, 2021 Results on Nov 12, 2020Bhagawati Oxygen Limited announced that they will report Q2, 2021 results on Nov 12, 2020Reported Earnings • Sep 18First quarter earnings releasedOver the last 12 months the company has reported total losses of ₹5.25m, with losses widening by 195% from the prior year. Total revenue was ₹16.7m over the last 12 months, down 79% from the prior year.お知らせ • Sep 10Bhagawati Oxygen Limited to Report Q1, 2021 Results on Sep 15, 2020Bhagawati Oxygen Limited announced that they will report Q1, 2021 results on Sep 15, 2020株主還元509449IN ChemicalsIN 市場7D9.0%0.3%0.4%1Y-39.2%-3.3%-0.6%株主還元を見る業界別リターン: 509449過去 1 年間で-3.3 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: 509449は、過去 1 年間で-0.6 % のリターンを上げたIndian市場を下回りました。価格変動Is 509449's price volatile compared to industry and market?509449 volatility509449 Average Weekly Movement9.0%Chemicals Industry Average Movement7.4%Market Average Movement7.2%10% most volatile stocks in IN Market10.3%10% least volatile stocks in IN Market4.8%安定した株価: 509449の株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 509449の weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト197215Himanshu Sharmaglobalbol.com/oxygen/インドで工業用ガスを製造・供給。ガス部門と電力部門を通じて事業を展開。製錬、製鋼、半導体、肥料、石油精製などの産業用途向けに、酸素、窒素、アルゴン、二酸化炭素、溶解アセチレン、水素、ヘリウム、圧縮空気、電子グレードや商用グレードのガス、混合ガス、校正用ガスなどを提供している。また、酸素、窒素、アルゴンなどを製造する各種オンサイトガス製造プラントの建設・運営や、ガスハンドリング・配給システムの設計・販売も行っている。さらに、空気分離プラント、クロスカントリー・ガス・パイプライン・システム、極低温液体貯蔵およびガス処理システムなどの設計、エンジニアリング、建設を含むターンキー請負ソリューションも提供している。また、風力発電の発電・供給も行っている。バガワティ・オキシジェン・リミテッドは1972年に設立され、インドのバラブガルに本社を置いている。もっと見るBhagawati Oxygen Limited 基礎のまとめBhagawati Oxygen の収益と売上を時価総額と比較するとどうか。509449 基礎統計学時価総額₹80.93m収益（TTM）₹1.47m売上高(TTM)₹4.89m55.0xPER（株価収益率16.5xP/Sレシオ509449 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計509449 損益計算書（TTM）収益₹4.89m売上原価₹1.15m売上総利益₹3.75mその他の費用₹2.27m収益₹1.47m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）0.64グロス・マージン76.57%純利益率30.09%有利子負債／自己資本比率16.0%509449 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/30 18:50終値2026/05/29 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bhagawati Oxygen Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹32.10, the stock trades at a trailing P/E ratio of 50.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 16% over the past three years.
お知らせ • May 19Bhagawati Oxygen Limited to Report Q4, 2026 Results on May 29, 2026Bhagawati Oxygen Limited announced that they will report Q4, 2026 results on May 29, 2026
Buy Or Sell Opportunity • Mar 11Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹42.00. The fair value is estimated to be ₹33.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.4% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Feb 07Third quarter 2026 earnings released: ₹0.33 loss per share (vs ₹0.89 loss in 3Q 2025)Third quarter 2026 results: ₹0.33 loss per share (improved from ₹0.89 loss in 3Q 2025). Revenue: ₹3.41m (up 31% from 3Q 2025). Net loss: ₹762.0k (loss narrowed 63% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 29Bhagawati Oxygen Limited to Report Q3, 2026 Results on Feb 06, 2026Bhagawati Oxygen Limited announced that they will report Q3, 2026 results on Feb 06, 2026
New Risk • Dec 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹7.0m revenue, or US$79k). Market cap is less than US$10m (₹102.9m market cap, or US$1.15m). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹32.10, the stock trades at a trailing P/E ratio of 50.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 16% over the past three years.
お知らせ • May 19Bhagawati Oxygen Limited to Report Q4, 2026 Results on May 29, 2026Bhagawati Oxygen Limited announced that they will report Q4, 2026 results on May 29, 2026
Buy Or Sell Opportunity • Mar 11Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 4.4% to ₹42.00. The fair value is estimated to be ₹33.78, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 5.4% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Feb 07Third quarter 2026 earnings released: ₹0.33 loss per share (vs ₹0.89 loss in 3Q 2025)Third quarter 2026 results: ₹0.33 loss per share (improved from ₹0.89 loss in 3Q 2025). Revenue: ₹3.41m (up 31% from 3Q 2025). Net loss: ₹762.0k (loss narrowed 63% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 29Bhagawati Oxygen Limited to Report Q3, 2026 Results on Feb 06, 2026Bhagawati Oxygen Limited announced that they will report Q3, 2026 results on Feb 06, 2026
New Risk • Dec 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹7.0m revenue, or US$79k). Market cap is less than US$10m (₹102.9m market cap, or US$1.15m). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Large one-off items impacting financial results.
Reported Earnings • Nov 16Second quarter 2026 earnings released: EPS: ₹0.49 (vs ₹0.84 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹0.49 (up from ₹0.84 loss in 2Q 2025). Revenue: ₹5.94m (up 95% from 2Q 2025). Net income: ₹1.13m (up ₹3.06m from 2Q 2025). Profit margin: 19% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 07Bhagawati Oxygen Limited to Report Q2, 2026 Results on Nov 14, 2025Bhagawati Oxygen Limited announced that they will report Q2, 2026 results on Nov 14, 2025
お知らせ • Sep 01Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2025Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2025, at 15:00 Indian Standard Time. Location: plot no. 5, sector - 25, ballabhgarh, haryana- 121004, haryana India
New Risk • Aug 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹11m revenue, or US$122k). Market cap is less than US$10m (₹93.7m market cap, or US$1.06m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). Share price has been volatile over the past 3 months (6.8% average weekly change).
お知らせ • Aug 02Bhagawati Oxygen Limited to Report Q1, 2026 Results on Aug 12, 2025Bhagawati Oxygen Limited announced that they will report Q1, 2026 results on Aug 12, 2025
New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$1m (₹11m revenue, or US$125k). Market cap is less than US$10m (₹106.9m market cap, or US$1.25m).
New Risk • May 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹11m revenue, or US$125k). Market cap is less than US$10m (₹140.2m market cap, or US$1.64m). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).
お知らせ • May 22Bhagawati Oxygen Limited to Report Q4, 2025 Results on May 30, 2025Bhagawati Oxygen Limited announced that they will report Q4, 2025 results on May 30, 2025
Reported Earnings • Feb 14Third quarter 2025 earnings released: ₹0.89 loss per share (vs ₹2.25 loss in 3Q 2024)Third quarter 2025 results: ₹0.89 loss per share (improved from ₹2.25 loss in 3Q 2024). Net loss: ₹2.06m (loss narrowed 61% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
お知らせ • Feb 04Bhagawati Oxygen Limited to Report Q3, 2025 Results on Feb 12, 2025Bhagawati Oxygen Limited announced that they will report Q3, 2025 results on Feb 12, 2025
New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹8.4m revenue, or US$98k). Market cap is less than US$10m (₹147.9m market cap, or US$1.73m). Minor Risk Share price has been volatile over the past 3 months (7.6% average weekly change).
お知らせ • Nov 06Bhagawati Oxygen Limited to Report Q2, 2025 Results on Nov 14, 2024Bhagawati Oxygen Limited announced that they will report Q2, 2025 results on Nov 14, 2024
Board Change • Sep 07Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Sanjay Rai was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 03Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2024Bhagawati Oxygen Limited, Annual General Meeting, Sep 26, 2024, at 15:00 Indian Standard Time. Location: plot no. 5, sector - 25, ballabhgarh, haryana- 121004, haryana India
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improves as stock rises 34%After last week's 34% share price gain to ₹70.97, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years.
New Risk • Aug 28New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (₹6.5m revenue, or US$77k). Market cap is less than US$10m (₹148.4m market cap, or US$1.77m). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹52.52, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 53% over the past three years.
Reported Earnings • Aug 11First quarter 2025 earnings released: ₹0.84 loss per share (vs ₹4.30 loss in 1Q 2024)First quarter 2025 results: ₹0.84 loss per share (improved from ₹4.30 loss in 1Q 2024). Net loss: ₹1.95m (loss narrowed 80% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 31Bhagawati Oxygen Limited to Report Q1, 2025 Results on Aug 08, 2024Bhagawati Oxygen Limited announced that they will report Q1, 2025 results on Aug 08, 2024
New Risk • Jun 04New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 64% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (64% accrual ratio). Revenue is less than US$1m (₹71m revenue, or US$851k). Market cap is less than US$10m (₹99.4m market cap, or US$1.19m). Minor Risk Share price has been volatile over the past 3 months (7.9% average weekly change).
Reported Earnings • Jun 04Full year 2024 earnings released: EPS: ₹1.78 (vs ₹10.47 loss in FY 2023)Full year 2024 results: EPS: ₹1.78 (up from ₹10.47 loss in FY 2023). Revenue: ₹71.1m (up ₹63.7m from FY 2023). Net income: ₹4.11m (up ₹28.3m from FY 2023). Profit margin: 5.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • May 19Bhagawati Oxygen Limited to Report Q4, 2024 Results on May 30, 2024Bhagawati Oxygen Limited announced that they will report Q4, 2024 results on May 30, 2024
Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹51.54, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 94% over the past three years.
Reported Earnings • Feb 14Third quarter 2024 earnings released: ₹2.25 loss per share (vs ₹3.37 loss in 3Q 2023)Third quarter 2024 results: ₹2.25 loss per share (improved from ₹3.37 loss in 3Q 2023). Revenue: ₹700.0k (down 48% from 3Q 2023). Net loss: ₹5.21m (loss narrowed 33% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 44% per year whereas the company’s share price has increased by 46% per year.
Valuation Update With 7 Day Price Move • Dec 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹44.10, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 139% over the past three years.
Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹15.70 (vs ₹1.27 loss in 2Q 2023)Second quarter 2024 results: EPS: ₹15.70 (up from ₹1.27 loss in 2Q 2023). Revenue: ₹66.6m (up ₹63.7m from 2Q 2023). Net income: ₹36.3m (up ₹39.2m from 2Q 2023). Profit margin: 55% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Sep 05Bhagawati Oxygen Limited, Annual General Meeting, Sep 27, 2023Bhagawati Oxygen Limited, Annual General Meeting, Sep 27, 2023, at 13:00 Indian Standard Time. Location: Plot No. 5, Sector- 25, Ballabhgarh Haryana India Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the Report of the Directors and Auditors thereon; to appoint a Director in place of Mr. Suresh Kumar Sharma who retires by rotation at this Annual General Meeting and being eligible offers himself for re-appointment; to consider reappointment of Mr. Suresh Kumar Sharmaas the whole-time director; to consider reappointment of Mr. Himanshu Sharmaas the managing director; and to consider appointment of Mr. Sanjay Kumar Raias an independent director.
お知らせ • Aug 04Bhagawati Oxygen Limited to Report Q1, 2024 Results on Aug 11, 2023Bhagawati Oxygen Limited announced that they will report Q1, 2024 results After-Market on Aug 11, 2023
Reported Earnings • Jun 01Full year 2023 earnings released: ₹10.47 loss per share (vs ₹12.19 loss in FY 2022)Full year 2023 results: ₹10.47 loss per share (improved from ₹12.19 loss in FY 2022). Net loss: ₹24.2m (loss narrowed 14% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has increased by 62% per year, which means it is well ahead of earnings.
お知らせ • May 23Bhagawati Oxygen Limited to Report Fiscal Year 2023 Results on May 30, 2023Bhagawati Oxygen Limited announced that they will report fiscal year 2023 results on May 30, 2023
Reported Earnings • Feb 16Third quarter 2023 earnings released: ₹3.37 loss per share (vs ₹3.54 loss in 3Q 2022)Third quarter 2023 results: ₹3.37 loss per share (improved from ₹3.54 loss in 3Q 2022). Net loss: ₹7.81m (loss narrowed 4.7% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 82% per year, which means it is well ahead of earnings.
お知らせ • Feb 04Bhagawati Oxygen Limited to Report Q3, 2023 Results on Feb 14, 2023Bhagawati Oxygen Limited announced that they will report Q3, 2023 results on Feb 14, 2023
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 4 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Bipin Lal was the last independent director to join the board, commencing their role in 2003. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 05Bhagawati Oxygen Limited to Report Q2, 2023 Results on Nov 12, 2022Bhagawati Oxygen Limited announced that they will report Q2, 2023 results on Nov 12, 2022
お知らせ • Aug 26Bhagawati Oxygen Limited, Annual General Meeting, Sep 20, 2022Bhagawati Oxygen Limited, Annual General Meeting, Sep 20, 2022, at 13:00 Indian Standard Time. Location: No. 5, Sector - 25, Ballabhgarh, Haryana- 121004 Ballabhgarh Haryana India Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Report of the Directors and Auditors thereon; to consider appoint Director in place of Mrs Jaya Sharma who retires by rotation at this Annual General Meeting and being eligible offers herself for re-appointment; and to consider other matters.
Reported Earnings • Aug 14First quarter 2023 earnings released: ₹2.99 loss per share (vs ₹2.71 loss in 1Q 2022)First quarter 2023 results: ₹2.99 loss per share (down from ₹2.71 loss in 1Q 2022). Net loss: ₹6.91m (loss widened 10% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.
お知らせ • May 21Bhagawati Oxygen Limited to Report Q4, 2022 Results on May 27, 2022Bhagawati Oxygen Limited announced that they will report Q4, 2022 results on May 27, 2022
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 4 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Bipin Lal was the last independent director to join the board, commencing their role in 2003. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: ₹3.54 loss per share (up from ₹3.90 loss in 3Q 2021). Net loss: ₹8.19m (loss narrowed 9.2% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 04Full year 2021 earnings released: ₹13.42 loss per share (vs ₹0.27 loss in FY 2020)Full year 2021 results: Net loss: ₹31.0m (loss widened ₹30.4m from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 17Third quarter 2021 earnings released: ₹3.90 loss per share (vs ₹3.74 profit in 3Q 2020)Third quarter 2021 results: Net loss: ₹9.02m (down 204% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 76% per year but the company’s share price has only fallen by 28% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 04Bhagawati Oxygen Limited to Report Q3, 2021 Results on Feb 12, 2021Bhagawati Oxygen Limited announced that they will report Q3, 2021 results on Feb 12, 2021
Is New 90 Day High Low • Jan 29New 90-day low: ₹12.45The company is down 21% from its price of ₹15.80 on 30 October 2020. The Indian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Dec 08New 90-day high: ₹19.05The company is up 2.0% from its price of ₹18.75 on 09 September 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period.
お知らせ • Dec 04Bhagawati Oxygen Limited, Annual General Meeting, Dec 30, 2020Bhagawati Oxygen Limited, Annual General Meeting, Dec 30, 2020, at 15:00 Indian Standard Time. Location: at the Registered Office of the Company at Plot No. 5, Sector - 25, Ballabgarh Haryana India Agenda: To consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2020, together with the Report of the Directors and Auditors thereon; and to re-appoint a Director in place of Ms Jaya Sharma (DIN 07135989) who retire by rotation at this Annual General Meeting and being eligible offers herself for re-appointment.
Is New 90 Day High Low • Nov 10New 90-day low: ₹12.55The company is down 8.0% from its price of ₹13.70 on 12 August 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
お知らせ • Nov 04Bhagawati Oxygen Limited to Report Q2, 2021 Results on Nov 12, 2020Bhagawati Oxygen Limited announced that they will report Q2, 2021 results on Nov 12, 2020
Reported Earnings • Sep 18First quarter earnings releasedOver the last 12 months the company has reported total losses of ₹5.25m, with losses widening by 195% from the prior year. Total revenue was ₹16.7m over the last 12 months, down 79% from the prior year.
お知らせ • Sep 10Bhagawati Oxygen Limited to Report Q1, 2021 Results on Sep 15, 2020Bhagawati Oxygen Limited announced that they will report Q1, 2021 results on Sep 15, 2020
